Rentokil Initial Posts 3.8% Revenue Rise and 24.5% Cash Flow Jump
Group revenue rose 3.8% to $6.9 billion in FY2025 driven by 2.6% organic growth, while adjusted operating profit climbed 5.4% to just over $1 billion, delivering a 15.5% margin. Free cash flow surged 24.5% to $615 million and net debt fell to $3.65 billion, supporting a 3% dividend hike and funding 36 bolt-on acquisitions.
1. Group Financial Performance
In 2025, group revenue increased 3.8% to $6.9 billion driven by 2.6% organic growth, while adjusted operating profit rose 5.4% to just over $1 billion, delivering a 15.5% margin and benefiting from $25 million of in-year cost savings.
2. Regional Highlights
North America revenue climbed 3.2% to $4.3 billion with organic growth of 2.3%, lifting adjusted operating profit 5.1% to $749 million at a 17.4% margin; international operations delivered 4.8% revenue growth to $2.6 billion and a 19.8% profit margin on $518 million of earnings.
3. Balance Sheet and Cash Flow
Free cash flow surged 24.5% to $615 million with a 98% conversion rate, net debt fell to $3.65 billion (2.6x leverage), and the full-year dividend increased 3% to $0.1239 per share.
4. Strategic Initiatives and Outlook
The termite provision rose by $201 million with similar expected payments in 2026, 36 bolt-on acquisitions were completed, and the company plans to expand to 220 local branches in North America by end-2026 while managing ongoing transformation costs.